Arden Trust’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$1.61M Sell
104,297
-865
-0.8% -$12.4K 0.22% 69
2024
Q1
$1.55M Sell
105,162
-3,318
-3% -$45.9K 0.22% 77
2023
Q4
$1.55M Buy
108,480
+2,473
+2% +$35.1K 0.23% 68
2023
Q3
$1.48M Buy
106,007
+68,090
+180% +$871K 0.25% 63
2023
Q2
$446K Buy
37,917
+25,891
+215% +$295K 0.07% 154
2023
Q1
$139K Buy
+12,026
New +$149K 0.03% 282

Other funds holding SBRA

Arden Trust's SBRA Position: Q2 2024 in Review

Arden Trust reduced its Sabra Healthcare REIT (SBRA) stake by 0.82% in Q2 2024, selling an estimated $12.4K and leaving 104,297 shares worth $1.61M. The position accounts for 0.22% of the portfolio, ranked #69.

Arden Trust first reported a position in SBRA in Q1 2023 and has held it in 6 quarters since. 355 funds tracked by Wall St. Rank hold SBRA as of Q2 2024.

  • Arden Trust held 104,297 shares of Sabra Healthcare REIT worth $1.61M as of Q2 2024.
  • Arden Trust sold 865 Sabra Healthcare REIT shares in Q2 2024, an estimated $12.4K.
  • Sabra Healthcare REIT made up 0.22% of Arden Trust's portfolio in Q2 2024, its #69 holding.
  • Arden Trust first reported a position in Sabra Healthcare REIT in Q1 2023 and has held it in 6 quarters since.
  • 355 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2024.

Based on Arden Trust's 13F filing for Q2 2024, filed 9 Jul 2024.